We are pleased to announce the official launch of QuarkBio’s product website – MIRA™ (miRNA-based Receptivity Analysis) www.mirababies.com MIRA™ is a preimplantation testing solution that analyzes endometrial receptivity during the in vitro fertilization process in order to enhance treatment success.
Neoline, a leading provider for genetic testing solutions and consumables, will be providing MIRA’s endometrial receptivity testing services to China, Hong Kong, and Macau clinics and patients starting summer of 2020. Contact us today to get an early preview of MIRA.
Genetics Generation Advancement Corporation (GGA), a leader for preimplantation genetic testing services in Asia, has officially been signed on as MIRA’s service distributor in Taiwan, Southeast Asia, and Japan. MIRA services are now being offered through GGA’s CAP-certified laboratory. Contact us today for a one-on-one
MIRA, our miRNA-based endometrial receptivity analysis, has officially been launched for service worldwide. Contact us today for more product information and see if this is a good fit for you and your patients.